Pancreatic Cancer Debate: Optimal Therapy - Adjuvant Folfirinox

Pancreatic Cancer Debate: Optimal Therapy - Adjuvant FOLFIRINOX

Debate: Optimal adjuvant therapy for resected pancreatic cancer? - Gem/Nab-Paclitaxel or FOLFIRINOX

Pancreatic Cancer Debate: Optimal Therapy - Preoperative Chemo/Chemoradiotherapy

Debate: Optimal therapy for patients with resectable pancreatic cancer - Neoadjuvant chemotherapy

Debate 9: Optimal Adjuvant Therapy in Pancreatic Cancer? - Intensified chemotherapy

Resectable Pancreatic Cancer Debate: Total Neoadjuvant vs Adjuvant Therapy - Total Neoadjuvant

Debate: Optimal chemotherapy backbone for targeted agents in pancreatic cancer? - FOLFIRINOX

Debate: Optimal therapy for patients with resectable pancreatic cancer - Surgery plus adjuvant chemo

Debate: Optimal neoadjuvant strategy in pancreatic cancer - Chemotherapy alone

Debate: Optimal adjuvant chemotherapy for resected pancreatic cancer - Gemcitabine/capecitabine

Debate 10: What do we do after FOLFIRINOX? - Gemcitabine is Standard

Debate: How to treat borderline, resectable pancreatic cancer? - Chemotherapy alone

Resectable Pancreatic Cancer Debate: Total Neoadjuvant vs Adjuvant Therapy - Adjuvant Therapy

NEPAFOX: adjuvant gemcitabine vs. FOLFIRINOX in resectable pancreatic cancer

FOLFIRINOX in Metastatic Pancreatic Cancer

Pancreatic Cancer Adjuvant Therapy

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer (ЖК18.09.2021)

Онкология от А до Я

Debate: Optimal adjuvant chemotherapy for resected pancreatic cancer - Gemcitabine/nab-paclitaxel

FOLFIRINOX-Based Regimens for Pancreatic Cancer

Debate 9: Optimal Adjuvant Therapy in Pancreatic Cancer? - Gemcitabine alone